Jade Biosciences (JBIO) Change in Acquisitions & Divestments (2022 - 2026)

Jade Biosciences (JBIO) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $65.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 409.17% year-over-year to $65.4 million; the trailing twelve-month figure through Mar 2026 stood at $112.4 million (up 72.99% YoY), and the FY2025 full-year result was $14.4 million, down 80.96% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $65.4 million, up from $12.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $65.4 million in Q1 2026 and bottomed at $12.5 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $30.6 million (2022), against an average of $31.8 million.
• The widest annual swing landed in 2024, when Change in Acquisitions & Divestments tumbled 60.81%; it then soared 409.17% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $64.8 million in 2022, then sank by 48.26% to $33.5 million in 2023, then slumped by 60.81% to $13.1 million in 2024, then fell by 2.13% to $12.8 million in 2025, then jumped by 409.17% to $65.4 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $65.4 million (Q1 2026), $12.8 million (Q1 2025), and $13.1 million (Q4 2024), per Business Quant data.

Peer Comparison